We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.78%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$20.9B
AUM Growth
+$2.5B
Cap. Flow
+$1.34B
Cap. Flow %
6.41%
Top 10 Hldgs %
19.15%
Holding
3,219
New
357
Increased
1,640
Reduced
999
Closed
136

Sector Composition

Rank Sector Weight
1 Technology 9.32%
2 Consumer Discretionary 5.02%
3 Financials 4.84%
4 Healthcare 4.11%
5 Communication Services 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WTW icon
2276
Willis Towers Watson
WTW
$30.9B
$381K ﹤0.01%
1,657
-31
-2% -$7.71K
Y
2277
DELISTED
Alleghany Corp
Y
$381K ﹤0.01%
571
-40
-7% -$27.5K
EG icon
2278
Everest Group
EG
$14B
$380K ﹤0.01%
+1,507
New +$392K
GAB icon
2279
Gabelli Equity Trust
GAB
$1.81B
$380K ﹤0.01%
55,073
-1,253
-2% -$8.78K
MPB icon
2280
Mid Penn Bancorp
MPB
$974M
$380K ﹤0.01%
13,856
PK icon
2281
Park Hotels & Resorts
PK
$3.01B
$380K ﹤0.01%
18,459
-1,200
-6% -$25.7K
THO icon
2282
Thor Industries
THO
$4.1B
$380K ﹤0.01%
3,361
+874
+35% +$111K
SWCH
2283
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$380K ﹤0.01%
18,010
+924
+5% +$17.7K
UAUG icon
2284
Innovator US Equity Ultra Buffer ETF August
UAUG
$180M
$379K ﹤0.01%
13,262
-230
-2% -$6.54K
DRNA
2285
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$377K ﹤0.01%
+10,098
New +$310K
EDIV icon
2286
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
$376K ﹤0.01%
12,549
-265
-2% -$8.05K
HEAL
2287
Global X Funds Global X HealthTech ETF
HEAL
$31M
$376K ﹤0.01%
6,492
-1,186
-15% -$67.4K
FXU icon
2288
First Trust Utilities AlphaDEX Fund
FXU
$829M
$375K ﹤0.01%
12,540
-1,863
-13% -$57.1K
MED icon
2289
Medifast
MED
$131M
$375K ﹤0.01%
1,327
+83
+7% +$22.5K
SIX
2290
DELISTED
Six Flags Entertainment Corp.
SIX
$375K ﹤0.01%
8,665
-22,205
-72% -$1M
KJUL icon
2291
Innovator US Small Cap Power Buffer ETF July
KJUL
$226M
$374K ﹤0.01%
14,055
-2,285
-14% -$60.6K
XLRN
2292
DELISTED
Acceleron Pharma
XLRN
$373K ﹤0.01%
2,974
+54
+2% +$6.81K
BATT icon
2293
Amplify Lithium & Battery Technology ETF
BATT
$124M
$372K ﹤0.01%
+20,711
New +$336K
GPI icon
2294
Group 1 Automotive
GPI
$3.12B
$372K ﹤0.01%
2,412
SFYF icon
2295
SoFi Social 50 ETF
SFYF
$42.6M
$372K ﹤0.01%
+9,316
New +$308K
SPFF icon
2296
Global X SuperIncome Preferred ETF
SPFF
$144M
$372K ﹤0.01%
30,809
+15,777
+105% +$189K
VTA
2297
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$372K ﹤0.01%
31,346
-962
-3% -$11.2K
CMC icon
2298
Commercial Metals
CMC
$8.01B
$371K ﹤0.01%
12,069
+2,480
+26% +$76.8K
IVAL icon
2299
Alpha Architect International Quantitative Value ETF
IVAL
$223M
$371K ﹤0.01%
12,766
+1,025
+9% +$30.3K
LEO
2300
BNY Mellon Strategic Municipals
LEO
$388M
$371K ﹤0.01%
41,351
+426
+1% +$3.75K

Similar funds

Cambridge Investment Research Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Cambridge Investment Research Advisors held 3,219 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Cambridge Investment Research Advisors deployed $1.34B of net new capital in Q2 2021, opening 357 new positions and adding to 1,640 existing holdings. Its largest new stake was Vanguard Morningstar Growth ETF: 2,637,318 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 8.9% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Vanguard Short-Term Treasury ETF, an estimated $17.7M trimmed.

  • Cambridge Investment Research Advisors's largest Q2 2021 buy was Vanguard Morningstar Growth ETF: 2,637,318 shares worth $126M.
  • Cambridge Investment Research Advisors added most to FS KKR Capital in Q2 2021, an estimated $36M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2021 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $17.7M.
  • Cambridge Investment Research Advisors fully exited Teucrium Corn Fund in Q2 2021, selling an estimated $4.14M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $20.9B portfolio in Q2 2021.
  • Cambridge Investment Research Advisors opened 357 new positions and closed 136 in Q2 2021.
  • Cambridge Investment Research Advisors's portfolio value rose 14% quarter-over-quarter to $20.9B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.